The Korean Journal of Pain

  • 제37권2호
  • /
  • Pages.119-131
  • /
  • 2024
  • /
  • 2005-9159(pISSN)
  • /
  • 2093-0569(eISSN)
대한통증학회 (The Korean Pain Society)
권호 표지
DOI QR코드

DOI QR Code

Updated guidelines for prescribing opioids to treat patients with chronic non-cancer pain in Korea: developed by committee on hospice and palliative care of the Korean Pain Society

  • Minsoo Kim (Department of Anesthesiology and Pain Medicine, Kangwon National University Hospital, College of Medicine, Kangwon National University) ;
  • Sun Kyung Park (Department of Anesthesiology and Pain Medicine, Jeju National University College of Medicine) ;
  • Woong Mo Kim (Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School) ;
  • Eunsoo Kim (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) ;
  • Hyuckgoo Kim (Department of Anesthesiology and Pain Medicine, College of Medicine, Yeungnam University) ;
  • Jun-Mo Park (Department of Anesthesiology and Pain Medicine, Kyungpook National University Hospital Medicine, Kyungpook National University) ;
  • Seong-Soo Choi (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Eun Joo Choi (Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital)
  • 투고 : 2024.01.18
  • 심사 : 2024.03.04
  • 발행 : 2024.04.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

There are growing concerns regarding the safety of long-term treatment with opioids of patients with chronic non-cancer pain. In 2017, the Korean Pain Society (KPS) developed guidelines for opioid prescriptions for chronic non-cancer pain to guide physicians to prescribe opioids effectively and safely. Since then, investigations have provided updated data regarding opioid therapy for chronic non-cancer pain and have focused on initial dosing schedules, reassessment follow-ups, recommended dosage thresholds considering the risk-benefit ratio, dose-reducing schedules for tapering and discontinuation, adverse effects, and inadvertent problems resulting from inappropriate application of the previous guidelines. Herein, we have updated the previous KPS guidelines based on a comprehensive literature review and consensus development following discussions among experts affiliated with the Committee on Hospice and Palliative Care in the KPS. These guidelines may assist physicians in prescribing opioids for chronic non-cancer pain in adult outpatient settings, but should not to be regarded as an inflexible standard. Clinical judgements by the attending physician and patient-centered decisions should always be prioritized.

키워드

참고문헌

  1. Manchikanti L, Kaye AM, Knezevic NN, McAnally H, Slavin K, Trescot AM, et al. Responsible, safe, and effective prescription of opioids for chronic noncancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician 2017; 20: S3-92. 
  2. Hauser W, Morlion B, Vowles KE, Bannister K, Buchser E, Casale R, et al. European* clinical practice recommendations on opioids for chronic noncancer pain - Part 1: role of opioids in the management of chronic noncancer pain. Eur J Pain 2021; 25: 949-68.  https://doi.org/10.1002/ejp.1736
  3. Oh TK, Jeon YT, Choi JW. Trends in chronic opioid use and association with five-year survival in South Korea: a population-based cohort study. Br J Anaesth 2019; 123: 655-63.  https://doi.org/10.1016/j.bja.2019.08.012
  4. Noh Y, Heo KN, Yu YM, Lee JY, Ah YM. Trends in potentially inappropriate opioid prescribing and associated risk factors among Korean noncancer patients prescribed non-injectable opioid analgesics. Ther Adv Drug Saf 2022; 13: 20420986221091001. 
  5. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 1980; 302: 123. 
  6. Rummans TA, Burton MC, Dawson NL. How good intentions contributed to bad outcomes: the opioid crisis. Mayo Clin Proc 2018; 93: 344-50.  https://doi.org/10.1016/j.mayocp.2017.12.020
  7. Yang J, Bauer BA, Wahner-Roedler DL, Chon TY, Xiao L. The modified WHO analgesic ladder: is it appropriate for chronic non-cancer pain? J Pain Res 2020; 13: 411-7.  https://doi.org/10.2147/JPR.S244173
  8. Kim ED, Lee JY, Son JS, Byeon GJ, Yeo JS, Kim DW, et al; Opioids Research Group in the Korean Pain Society. Guidelines for prescribing opioids for chronic non-cancer pain in Korea. Korean J Pain 2017; 30: 18-33.  https://doi.org/10.3344/kjp.2017.30.1.18
  9. Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain - United States, 2022. MMWR Recomm Rep 2022; 71: 1-95. 
  10. Turk DC, Robinson JP. Multidisciplinary assessment of patients with chronic pain. In: Bonica's management of pain. 5th ed. Edited by Ballantyne JC, Fishman SM, Rathmell JP. Wolters Kluwer. 2019, pp 313-24. 
  11. Kim S, Kim E, Suh HS. Cost-effectiveness of an opioid abuse-prevention program using the narcotics information management system in South Korea. Value Health 2021; 24: 174-81.  https://doi.org/10.1016/j.jval.2020.12.002
  12. Lee J, Noh Y, Lee S. Evaluation of preventable adverse drug reactions by implementation of the nationwide network of prospective drug utilization review program in Korea. PLoS One 2018; 13: e0195434. 
  13. Busse JW, Sadeghirad B, Oparin Y, Chen E, Goshua A, May C, et al. Management of acute pain from non-low back, musculoskeletal injuries: a systematic review and network meta-analysis of randomized trials. Ann Intern Med 2020; 173: 730-8.  https://doi.org/10.7326/M19-3601
  14. Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial. JAMA 2018; 319: 872-82.  https://doi.org/10.1001/jama.2018.0899
  15. Neuropathic pain in adults: pharmacological management in non-specialist settings [Internet]. London: National Institute for Health and Care Excellence (NICE); 2020 Sep 22. (NICE Clinical Guidelines, No. 173.) Available at: https://www.ncbi.nlm.nih.gov/books/NBK552848/ 
  16. Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ 2017; 189: E659-66.  https://doi.org/10.1503/cmaj.170363
  17. Chou R, Hartung D, Turner J, Blazina I, Chan B, Levander X, et al. Opioid treatments for chronic pain [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Apr. (Comparative Effectiveness Review, No. 229.) Available at: https://www.ncbi.nlm.nih.gov/books/NBK556253/ 
  18. Miller M, Barber CW, Leatherman S, Fonda J, Hermos JA, Cho K, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med 2015; 175: 608-15.  https://doi.org/10.1001/jamainternmed.2014.8071
  19. Krcevski Skvarc N, Morlion B, Vowles KE, Bannister K, Buchsner E, Casale R, et al. European clinical practice recommendations on opioids for chronic noncancer pain - Part 2: special situations. Eur J Pain 2021; 25: 969-85.  https://doi.org/10.1002/ejp.1744
  20. Chou R, Deyo R, Devine B, Hansen R, Sullivan S, Jarvik JG, et al. The effectiveness and risks of long-term opioid treatment of chronic pain. Evid Rep Technol Assess (Full Rep) 2014; 218: 1-219. 
  21. Moisset X, Martinez V. Opioid use for the management of chronic non-cancer pain: French guidelines. Rev Neurol (Paris) 2016; 172: 337-8.  https://doi.org/10.1016/j.neurol.2016.05.004
  22. Kalso E, Simpson KH, Slappendel R, Dejonckheere J, Richarz U. Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine. BMC Med 2007; 5: 39. 
  23. Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 2013; 170: 834-51.  https://doi.org/10.1176/appi.ajp.2013.12060782
  24. O'Brien CP, Volkow N, Li TK. What's in a word? Addiction versus dependence in DSM-V. Am J Psychiatry 2006; 163: 764-5.  https://doi.org/10.1176/ajp.2006.163.5.764
  25. National Conference of State Legislatures. Prescribing policies: states confront opioid overdose epidemic [Internet]. National Conference of State Legislatures; 2020. Available at: https://www.ncsl.org/research/health/prescribing-policies-states-confront-opioid-overdose-epidemic 
  26. Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use - United States, 2006-2015. MMWR Morb Mortal Wkly Rep 2017; 66: 265-9.  https://doi.org/10.15585/mmwr.mm6610a1
  27. Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg 2017; 152: e170504. Erratum in: JAMA Surg 2019; 154: 272. 
  28. Mundkur ML, Franklin JM, Abdia Y, Huybrechts KF, Patorno E, Gagne JJ, et al. Days' supply of initial opioid analgesic prescriptions and additional fills for acute pain conditions treated in the primary care setting - United States, 2014. MMWR Morb Mortal Wkly Rep 2019; 68: 140-3.  https://doi.org/10.15585/mmwr.mm6806a3
  29. Chou R, Wagner J, Ahmed AY, Blazina I, Brodt E, Buckley DI, et al. Treatments for acute pain: a systematic review [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Dec. Report No.: 20(21)-EHC006. 
  30. Edlund MJ, Martin BC, Russo JE, DeVries A, Braden JB, Sullivan MD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain 2014; 30: 557-64.  https://doi.org/10.1097/AJP.0000000000000021
  31. Oliva EM, Bowe T, Manhapra A, Kertesz S, Hah JM, Henderson P, et al. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. BMJ 2020; 368: m283. 
  32. Rich RC, Chou R, Mariano ER, Dopp AL, Sullenger R, Burstin H; Pain Management Guidelines and Evidence Standards Working Group. Best practices, research gaps, and future priorities to support tapering patients on long-term opioid therapy for chronic non-cancer pain in outpatient settings. NAM Perspect 2020; 2020: 10.31478/202008c. 
  33. U.S. Food and Drug Administration. Safety Announcement. FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering [Internet]. U.S. Food and Drug Administration; 2019. Available at: https://www.fda.gov/Drugs/DrugSafety/ucm635038.htm 
  34. Mark TL, Parish W. Opioid medication discontinuation and risk of adverse opioid-related health care events. J Subst Abuse Treat 2019; 103: 58-63.  https://doi.org/10.1016/j.jsat.2019.05.001
  35. Dowell D, Compton WM, Giroir BP. Patient-centered reduction or discontinuation of long-term opioid analgesics: the HHS guide for clinicians. JAMA 2019; 322: 1855-6.  https://doi.org/10.1001/jama.2019.16409
  36. Joo SS, Hunter OO, Tamboli M, Leng JC, Harrison TK, Kassab K, et al. Implementation of a patient-specific tapering protocol at discharge decreases total opioid dose prescribed for 6 weeks after elective primary spine surgery. Reg Anesth Pain Med 2020; 45: 474-8.  https://doi.org/10.1136/rapm-2020-101324
  37. Tamboli M, Mariano ER, Gustafson KE, Briones BL, Hunter OO, Wang RR, et al. A multidisciplinary patient-specific opioid prescribing and tapering protocol is associated with a decrease in total opioid dose prescribed for six weeks after total hip arthroplasty. Pain Med 2020; 21: 1474-81.  https://doi.org/10.1093/pm/pnz260
  38. Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, et al. Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2019; 17: 977-1007.  https://doi.org/10.6004/jnccn.2019.0038
  39. Nielsen S, Degenhardt L, Hoban B, Gisev N. A synthesis of oral morphine equivalents (OME) for opioid utilisation studies. Pharmacoepidemiol Drug Saf 2016; 25: 733-7.  https://doi.org/10.1002/pds.3945
  40. Voon P, Karamouzian M, Kerr T. Chronic pain and opioid misuse: a review of reviews. Subst Abuse Treat Prev Policy 2017; 12: 36. 
  41. Savage SR, Joranson DE, Covington EC, Schnoll SH, Heit HA, Gilson AM. Definitions related to the medical use of opioids: evolution towards universal agreement. J Pain Symptom Manage 2003; 26: 655-67.  https://doi.org/10.1016/S0885-3924(03)00219-7
  42. Kosten TR, Rounsaville BJ, Babor TF, Spitzer RL, Williams JB. Substance-use disorders in DSM-III-R. Evidence for the dependence syndrome across different psychoactive substances. Br J Psychiatry 1987; 151: 834-43.  https://doi.org/10.1192/bjp.151.6.834
  43. Fainsinger RL, Thai V, Frank G, Fergusson J. What's in a word? Addiction versus dependence in DSM-V. Am J Psychiatry 2006; 163: 2014. 
  44. Miller SC. Language and addiction. Am J Psychiatry 2006; 163: 2015. 
  45. Streltzer J, Sullivan CR, Johnson B. Addiction versus dependence in pain management. Am J Psychiatry 2006; 163: 2016. 
  46. O'Brien C. Addiction and dependence in DSM-V. Addiction 2011; 106: 866-7.  https://doi.org/10.1111/j.1360-0443.2010.03144.x
  47. Ballantyne JC. Assessing the prevalence of opioid misuse, abuse, and addiction in chronic pain. Pain 2015; 156: 567-8.  https://doi.org/10.1097/j.pain.0000000000000105
  48. Ballantyne JC, Sullivan MD, Kolodny A. Opioid dependence vs addiction: a distinction without a difference? Arch Intern Med 2012; 172: 1342-3.  https://doi.org/10.1001/archinternmed.2012.3212
  49. Kosten TR, Baxter LE. Review article: effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment. Am J Addict 2019; 28: 55-62. https://doi.org/10.1111/ajad.12862